Vivani Medical Inc

VANI

Company Profile

  • Business description

    Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

  • Contact

    1350 South Loop Road
    AlamedaCA94502
    USA

    T: +1 415 506-8462

    https://www.vivani.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    36

Stocks News & Analysis

stocks

Eli Lilly earnings: Mounjaro/Zepbound’s massive volume growth more than counters price pressure

We’ve raised our fair value estimate of Lilly stock.
stocks

OpenAI missed multiple revenue targets - here’s why it likely won’t IPO this year

Plus, whichever AI company IPOs first defines what “good” looks like.
stocks

Lower production and higher prices for ASX hydrocarbon play

Improving pricing offsets severe weather impact on sales volumes.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,887.6017.100.19%
CAC 408,114.840.000.00%
DAX 4024,292.38337.821.41%
Dow JONES (US)49,652.14790.331.62%
FTSE 10010,378.82165.711.62%
HKSE25,776.53335.31-1.28%
NASDAQ24,892.31219.070.89%
Nikkei 22559,284.92632.54-1.06%
NZX 50 Index12,905.111.800.01%
S&P 5007,209.0173.061.02%
S&P/ASX 2008,665.8025.600.30%
SSE Composite Index4,112.164.650.11%

Market Movers